Physician

Melaku Gebremariam Demede, M.D.

According to 2025 Medicare claims, Melaku Demede, M.D. (NPI: 1396935763) practices cardiology in the Beckley, WV market, with the plurality of this provider's patient population coming from Raleigh, WV. This provider's primary affiliated billing organization is DEMBAL HEART & VASCULAR PLLC (NPI: 1770069163; TIN: 825485118) and primary practice location at 25801-9998. Demede is affiliated with the Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Demede's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 264 traditional Medicare patients, billed 808 HCPCS/CPT codes, and received $65,583 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 2,057 prescription claims across 249 beneficiaries totaling $226,366 in drug costs, led by Entresto (Sacubitril/Valsartan). 2022 DME data shows 11 claims. Open Payments data shows 61 records totaling $1,003. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $72,433 to $65,583. In contrast, Part D prescription costs have moved sharply higher in recent years, from $22,784 to $226,366. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	294	1,043	$72,433
2016	470	1,868	$88,895
2017	724	2,549	$118,389
2018	915	2,867	$146,927
2019	472	2,128	$169,487
2020	412	1,660	$142,715
2021	280	962	$72,517
2022	308	1,057	$73,638
2023	277	958	$71,345
2024	264	808	$65,583

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	488	$22,784
2016	91	710	$34,739
2017	96	553	$39,545
2018	230	1,624	$146,316
2019	212	1,609	$168,385
2020	121	476	$37,803
2021	93	441	$17,882
2022	246	1,773	$219,285
2023	257	1,865	$228,558
2024	249	2,057	$226,366

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	14	$28,814
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	13	$29,152
2022	N/R	11	$26,570
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	43	44	$192
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	54	98	$59
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	95	181	$54
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	111	116	$53
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	40	43	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	74	2,900	$63,346
Eliquis	Apixaban	37	1,890	$36,960
Farxiga	Dapagliflozin Propanediol	49	1,948	$36,742
Xarelto	Rivaroxaban	39	1,410	$25,815
Brilinta	Ticagrelor	41	1,530	$21,732

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$1,003	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Melaku Gebremariam Demede, M.D.?

Tedicare shows public-source Medicare data for Melaku Gebremariam Demede, M.D. (NPI 1396935763), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Melaku Gebremariam Demede, M.D. have ACO affiliation data?

Melaku Gebremariam Demede, M.D. is shown with ACO affiliation data for Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to Melaku Gebremariam Demede, M.D.?

Melaku Gebremariam Demede, M.D. is linked to DEMBAL HEART & VASCULAR PLLC (billing NPI 1770069163) in the available physician profile data.

Does Melaku Gebremariam Demede, M.D. have Open Payments data?

Melaku Gebremariam Demede, M.D. has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.